Exim Bank releases study on Indian chemical industry
Study titled ‘Indian Chemical Industry: Exploring Global Demand’, shows that Indian chemical industry has a lot of export…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘Mylan can set a new standard in the treatment of HIV/AIDS in India’
Mylan recently started commercial operations in India with the launch of 18 ARVs, including heat stable, combination, and…
ICDR rules in favour of Glenmark wins ruling to commercialise, distribute Crofelemer
The International Centre for Dispute Resolution (ICDR) ruled in favour of Glenmark on the arbitration claim it filed on August 8,…
India, Sri Lanka to jointly fund pharma hub
Sri Lankan pharma hub to be ready in the next two years, Pharmexcil to promote exports from India
Report on CDSCO functioning to be ready in three months
DCGI mulls rule to protect patients enrolled in clinical trials
Phase I trial of CSIR-IMTECH’s clot buster to start by end October
Ahmedabad’s Veeda CR to conduct the trial, CSIR aims to launch drug in India by 2014
Merck acquires Biochrom
The acquisition will strengthen Merck Millipore’s Process Solutions business unit
Wockhardt gets US FDA approval for generic version of anti-hypertensive drug Plendil
Will manufacture the felodipine API in its facility at Ankleshwar
Venus Remedies launches Trois for arthritic pain
Trois is a patent protected topical nano emulsion with all natural ingredients and has no side effects
IPAB postpones hearing on Natco’s CL for Bayer’s Nexavar to Sept 3
Focus shifts to Novartis India's challenge to Section 3 (d), scheduled for tomorrow